China's Hygeia Healthcare H1 profit rises

Hygeia Healthcare Holdings

27/08/2026 11:04

Overview
China oncology hospital operator's H1 revenue fell 1.4% yr/yr, net profit rose 4.7%
Company continued RMB300 mln share repurchase scheme, with RMB120 mln utilized so far
Board will not recommend a dividend for the six months ended June 30, 2026

Outlook
Company proposes to utilize RMB500 mln annually for shareholder returns through 2028

Result Drivers
PATIENT VOLUME - Co said total patient visits rose 4.1% yr/yr and outpatient visits increased 4.5%
SURGERY GROWTH - Number of surgeries performed rose 8.2% yr/yr, with complex surgeries up 17.8%
MARGIN IMPROVEMENT - Gross profit margin increased by 0.8 percentage points to 27.4%

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
RMB 1.96 bln
 
H1 Net Income Attributable
 
RMB 257.40 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Hygeia Healthcare Holdings Co., Limited is HK$16.70, about 77.1% above its August 27 closing price of HK$9.43
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 11 three months ago

Reuters Recommended Reads
Aug 25 - China's Hospital Corporation half-year profit drops on service revenue decline
Aug 26 - Singapore's Thomson Medical Group FY revenue rises on Singapore strength, Malaysia oncology contribution
Aug 26 - China's Hansoh Pharma posts 36% rise in first-half profit helped by innovative drug sales

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)